Literature DB >> 14627930

Measuring participation across impairment groups using the Craig Handicap Assessment Reporting Technique.

Nancy Walker1, David Mellick, C A Brooks, Gale G Whiteneck.   

Abstract

OBJECTIVE: To assess the efficacy, across a range of disability groups, of the Craig Handicap Assessment and Reporting Technique (CHART), a measure of societal participation.
DESIGN: Cross-sectional analysis survey methodology. A total of 1110 community-based, nonhospitalized Coloradans with spinal cord injury, traumatic brain injury, multiple sclerosis, stroke, burn, or amputation were interviewed twice, 2 wks apart, using the CHART and a single administration of the FIM.
RESULTS: Across all impairment groups, the intraclass correlation for the total score and the subscales of CHART-R were high. In addition, the CHART-R discriminated among the impairment categories in a direction that parallels increasing disability.
CONCLUSIONS: CHART may be an appropriate measure of handicap for a range of physical or cognitive impairments.

Entities:  

Mesh:

Year:  2003        PMID: 14627930     DOI: 10.1097/01.PHM.0000098041.42394.9A

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


  12 in total

1.  Changes in pain and quality of life in depressed individuals with spinal cord injury: does type of pain matter?

Authors:  Elizabeth J Richardson; Larry G Brooks; J Scott Richards; Charles H Bombardier; Jason Barber; Denise Tate; Martin B Forchheimer; Jesse R Fann
Journal:  J Spinal Cord Med       Date:  2016-03-04       Impact factor: 1.985

2.  Preliminary results for the PAR-PRO: a measure of home and community participation.

Authors:  Glenn V Ostir; Carl V Granger; Terrie Black; Pamela Roberts; Laura Burgos; Paula Martinkewiz; Kenneth J Ottenbacher
Journal:  Arch Phys Med Rehabil       Date:  2006-08       Impact factor: 3.966

3.  The effect of social integration on outcomes after major lower extremity amputation.

Authors:  Alexander T Hawkins; Anthony J Pallangyo; Ayesiga M Herman; Maria J Schaumeier; Ann D Smith; Nathanael D Hevelone; David M Crandell; Louis L Nguyen
Journal:  J Vasc Surg       Date:  2015-10-21       Impact factor: 4.268

4.  Depressive symptoms in adults with spina bifida.

Authors:  Brad E Dicianno; Nicholas Kinback; Melissa H Bellin; Laurie Chaikind; Alhaji M Buhari; Grayson N Holmbeck; T Andrew Zabel; Robert M Donlan; Diane M Collins
Journal:  Rehabil Psychol       Date:  2015-07-06

5.  Measuring community integration after spinal cord injury: validation of the Sydney psychosocial reintegration scale and community integration measure.

Authors:  Annelies De Wolf; Amanda Lane-Brown; Robyn L Tate; James Middleton; Ian D Cameron
Journal:  Qual Life Res       Date:  2010-06-27       Impact factor: 4.147

6.  Using the Rasch Model to Develop a Measure of Participation Capturing the Full Range of Participation Characteristics for the Patients with Hand Injuries.

Authors:  Maryam Farzad; Fereydoun Layeghi; Ali Hosseini; Gale Whiteneck; Ali Asgari
Journal:  J Hand Microsurg       Date:  2017-07-03

Review 7.  A review of instruments assessing participation in persons with spinal cord injury.

Authors:  V K Noonan; W C Miller; L Noreau
Journal:  Spinal Cord       Date:  2009-02-24       Impact factor: 2.772

8.  Participation following traumatic spinal cord injury: an evidence-based review for research.

Authors:  Susan R Magasi; Allen W Heinemann; Gale G Whiteneck
Journal:  J Spinal Cord Med       Date:  2008       Impact factor: 1.985

9.  Does attendance in SCI education courses impact health outcomes in acute rehabilitation?

Authors:  Milagros Evardone; Catherine S Wilson; Diana Weinel; Jason R Soble; Younghee Kang
Journal:  J Spinal Cord Med       Date:  2016-05-05       Impact factor: 1.985

10.  Association Between Time to Rehabilitation and Outcomes After Traumatic Spinal Cord Injury.

Authors:  Kurt R Herzer; Yuying Chen; Allen W Heinemann; Marlis González-Fernández
Journal:  Arch Phys Med Rehabil       Date:  2016-06-05       Impact factor: 3.966

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.